[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-35412":3,"doc-seo-35412":29},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"site_id":24,"html_lang":23,"table_of_contents":25,"faqs":26,"seo_title":13,"seo_description":14,"update_tm":27,"read_time":28},35412,34359740700684,"Finn","https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487",8,"Research & Report","Cardiovascular Stent Technologies for Coronary and Valvular Heart Disease: The Potential of 3D Printing for Stent Fabrication","Over the past two decades, stents have transformed treatment of cardiovascular diseases, especially coronary artery and valvular heart disease. This Review examines clinical challenges and manufacturing strategies for coronary and heart valve stents, emphasizing emerging 3D printing. It compares metallic and polymeric stents for coronary disease and summarizes metallic and biodegradable polymeric approaches for valvular disease. It also reviews key 3D-printing methods, their trade-offs, and regulatory considerations, showing opportunities for customized geometry, controlled degradation, and improved implantation in complex anatomies.","","cbCaimTFuu2QSYbE","https://ap.wps.com/l/cbCaimTFuu2QSYbE","pdf",2215652,1,25,"English","en",105,"# Introduction\n# Stents for CAD\n## Stents for valvular heart disease\n# Conventional production methods of cardiovascular stents\n## 3D printing of coronary and valvular stents\n# Future directions\n# Conclusions","[{\"question\":\"What clinical problems in coronary and valvular heart disease does the review focus on?\",\"answer\":\"The review highlights clinical challenges tied to coronary artery disease and valvular heart disease, and evaluates how manufacturing choices influence outcomes such as restenosis, thrombosis risk, biocompatibility, and vessel healing.\"},{\"question\":\"How do metallic and polymeric stents for coronary artery disease differ in key risks and performance?\",\"answer\":\"Metallic stents are described as having high durability but a higher risk of restenosis and poorer long-term biocompatibility, while biodegradable metallic and emerging polymeric stents aim to reduce late risks yet require improvements in long-term durability and mechanical properties.\"},{\"question\":\"What capabilities of 3D printing are presented for stent fabrication?\",\"answer\":\"3D printing is presented as enabling precision and customization of stent geometry, with potential advantages over traditional fabrication approaches such as laser cutting.\"}]",1782516504,63,null]